COMPARISON OF [I-123] BETA-CIT AND [I-123] IPCIT AS SINGLE-PHOTON EMISSION TOMOGRAPHY RADIOTRACERS FOR THE DOPAMINE TRANSPORTER IN NONHUMAN-PRIMATES

被引:12
|
作者
SCANLEY, BE
ALTIKRITI, MS
GANDELMAN, MS
LARUELLE, M
ZEAPONCE, Y
BALDWIN, RM
ZOGHBI, SS
HOFFER, PB
CHARNEY, DS
WANG, SY
NEUMEYER, JL
INNIS, RB
机构
[1] YALE UNIV,W HAVEN,CT 06516
[2] RES BIOCHEM INT,NATICK,MA 01760
来源
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1995年 / 22卷 / 01期
关键词
DOPAMINE TRANSPORTER; 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE; SINGLE-PHOTON EMISSION TOMOGRAPHY; CARBOISOPROPOXY-3-BETA-(4-IODOPHENYL)TROPANE;
D O I
10.1007/BF00997241
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Single-photon emission tomographic (SPET) imaging with the radiotracer [I-123] 2 beta-carbomethoxy-3 beta(4-iodophenyl)tropane ([I-123]beta-CIT) has been reported to be a useful in vivo measure of dopamine (DA) transporters. However, in addition to its high DA transporter affinity, beta-CIT also binds with high affinity to serotonin (5-HT) transporters. 2 beta-Carboisopropoxy-3 beta-(4-iodophenyl)tropane (IPCIT) has been demonstrated by in vitro studies to have higher selectivity for the DA transporter. We compared [I-123]beta-CIT and [I-123]IPCIT SPET imaging and plasma metabolite analyses in baboons to evaluate the potential advantages of [I-123]IPCIT for quantitative in vivo measurements of DA transporter densities. Both tracers had low levels (2% of total plasma I-123 activity) of lipophilic radiolabeled metabolites at 420 min. [I-123]IPCIT had significantly higher binding to plasma proteins. The average percent free (nonprotein bound) [I-123]beta-CIT and [I-123]IPCIT were 52%+/-7% and 14%+/-6%, respectively. Region of interest uptake data were normalized by injected dose and body weight. Consistent with the high density of 5-HT transporters in the midbrain and the lower 5-HT transporter affinity of IPCIT, the normalized peak specific midbrain uptake of [I-123]beta-CIT (1.7+/-0.5) was higher than that of [I-123]IPCIT (0.4+/-0.2). Consistent with its greater lipophilicity, [I-123]IPCIT had higher nonspecific uptake, such that normalized cerebellar uptake of [I-123]IPCIT was about twice that of [123]beta-CIT. The ratio of specific to nonspecific uptake in striatum was greater for [I-123]beta-CIT compared to [I-123]IPCIT; however, striatal binding potentials and distribution volumes were not significantly different. In conclusion, [I-123]IPCIT demonstrated in vivo a higher DA transporter selectivity and higher level of nonspecific uptake.
引用
收藏
页码:4 / 11
页数:8
相关论文
共 50 条
  • [1] [I-123]beta-CIT single-photon emission tomography in DOPA-Responsive dystonia
    Naumann, M
    Pirker, W
    Reiners, K
    Lange, K
    Becker, G
    MOVEMENT DISORDERS, 1997, 12 (03) : 448 - 451
  • [2] [I-123] BETA-CIT SPECT IMAGING OF THE DOPAMINE TRANSPORTER IN PARKINSONISM
    MAREK, K
    SEIBYL, JP
    FUSSELL, B
    SMITH, ED
    BALDWIN, RM
    HOFFER, PB
    INNIS, RB
    NEUROLOGY, 1995, 45 (04) : A219 - A220
  • [3] Analysis of the metabolites of [I-123] beta-CIT in plasma of human and nonhuman primates
    Heinz, A
    Jones, DW
    Gorey, JG
    Knable, MB
    Lee, KS
    Saunders, RC
    Weinberger, DR
    SYNAPSE, 1997, 25 (03) : 306 - 308
  • [4] SPECT IMAGING OF DOPAMINE AND SEROTONIN TRANSPORTERS WITH [I-123] BETA-CIT - PHARMACOLOGICAL CHARACTERIZATION OF BRAIN UPTAKE IN NONHUMAN-PRIMATES
    LARUELLE, M
    BALDWIN, RM
    MALISON, RT
    ZEAPONCE, Y
    ZOGHBI, SS
    ALTIKRITI, MS
    SYBIRSKA, EH
    ZIMMERMANN, RC
    WISNIEWSKI, G
    NEUMEYER, JL
    MILIUS, RA
    WANG, SY
    SMITH, EO
    ROTH, RH
    CHARNEY, DS
    HOFFER, PB
    INNIS, RB
    SYNAPSE, 1993, 13 (04) : 295 - 309
  • [5] Comparison of [I-123]FP-CIT and [I-123]beta-CIT for SPECT imaging of dopamine transporters in Parkinson's disease
    Seibyl, J
    Marek, K
    Sheff, K
    Neumeyer, J
    Innis, R
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 522 - 522
  • [6] Within subject comparison of [I-123]FP-CIT and [I-123]beta-CIT for SPECT imaging of dopamine transporters in Parkinson's disease
    Seibyl, JP
    Marek, K
    Sheff, K
    Innis, R
    NEUROLOGY, 1996, 46 (02) : 6094 - 6094
  • [7] [I-123]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls
    Tissingh, G
    Bergmans, P
    Booij, J
    Winogrodzka, A
    Stoof, JC
    Wolters, EC
    VanRoyen, EA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (09): : 1171 - 1174
  • [8] PHARMACOKINETICS OF THE 3 RADIOIODINATED DOPAMINE D-2 RECEPTOR LIGANDS [I-123] IBF, [I-123] EPIDEPRIDE AND [I-123] 2'-ISP IN NONHUMAN-PRIMATES
    BALDWIN, RM
    ZEAPONCE, Y
    ZOGHBI, SS
    ALTIKRITI, MS
    SEIBYL, JP
    SYBIRSKA, EH
    MALISON, RT
    LARUELLE, M
    CHARNEY, DS
    HOFFER, PB
    INNIS, RB
    NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (07): : 969 - 976
  • [9] [I-123] BETA-CIT SPECT IMAGING OF STRIATAL DOPAMINE TRANSPORTER BINDING IN TOURETTES DISORDER
    MALISON, RT
    MCDOUGLE, CJ
    VANDYCK, CH
    SCAHILL, L
    BALDWIN, RM
    SEIBYL, JP
    PRICE, LH
    LECKMAN, JF
    INNIS, RB
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (09): : 1359 - 1361
  • [10] SPECT IMAGING WITH [I-123] BETA-CIT DEMONSTRATES STRIATAL DOPAMINE TRANSPORTER LOSS IN PARKINSONISM
    MAREK, KL
    SEIBYL, JP
    SANDRIDGE, B
    FUSSELL, B
    SCANLEY, BE
    LARUELLE, M
    ABI-DARGHAM, A
    WALLACE, E
    BALDWIN, RM
    ZEAPONCE, Y
    ZOGHBI, S
    CHARNEY, DS
    WANG, S
    GAO, Y
    NEUMEYER, JL
    HOFFER, PB
    INNIS, RB
    NEUROLOGY, 1994, 44 (04) : A352 - A352